Assessment of the Interaction Between Urokinase and Reactive Site Mutants of Protein C Inhibitor
- 1 November 1997
- journal article
- Published by Springer Nature in Protein Journal
- Vol. 16 (8) , 819-828
- https://doi.org/10.1023/a:1026324102618
Abstract
Urokinase-type plasminogen activator (uPA) is a serine protease involved in pericellular proteolysis and tumor cell metastasis via plasmin-mediated degradation of extracellular matrix proteins....Keywords
This publication has 20 references indexed in Scilit:
- On the size of the active site in proteases. I. PapainPublished by Elsevier ,2005
- Intermolecular Interactions between Protein C Inhibitor and Coagulation ProteasesBiochemistry, 1995
- Reactive site mutants of recombinant protein C inhibitorBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
- Protease inhibitors: Role and potential therapeutic use in human cancerEuropean Journal Of Cancer, 1994
- Plasminogen activator inhibitor type-1 interacts exclusively with the proteinase domain of tissue plasminogen activatorBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1994
- Tumor-Associated Urokinase-Type Plasminogen Activator: Biological and Clinical SignificanceBiological Chemistry Hoppe-Seyler, 1992
- Substrate specificity of tissue-type and urokinase-type plasminogen activatorsBiochemical and Biophysical Research Communications, 1991
- Crystal and molecular structures of the complex of α-chymotrypsin with its inhibitor Turkey ovomucoid third domain at 1.8 Å resolutionJournal of Molecular Biology, 1987
- Adaptation of plasminogen activator sequences to known protease structuresFEBS Letters, 1983
- Stability and specificity of protein-protein interactions: The case of the trypsin-trypsin inhibitor complexesJournal of Molecular Biology, 1976